Press Digest: Financial Times - September 17

AstraZeneca

17/09/2026 04:19

Sept 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
     
Headlines
Breast cancer drug approved after UK pharma deal with Trump
Andy Burnham considers plan to give mayors greater oversight of water companies
Mark Walter and Todd Boehly sell Chelsea FC stakes to Clearlake for £950 million
Vodafone takes up to €1.1 billion hit from Drahi's German broadband deal
Overview
Britain's medicines watchdog approved AstraZeneca AZN.L and Daiichi Sankyo's 4568.T breast cancer treatment Enhertu for NHS use, in its first major decision since the UK revised drug cost-effectiveness thresholds. 
British Prime Minister Andy Burnham is considering reforms to England's water industry that would give mayors and other local leaders greater oversight role over regional water companies.
Clearlake Capital has agreed to buy the stakes held by Mark Walter and Todd Boehly in Chelsea FC in a deal valuing the club at about £5 billion ($6.68 billion), including debt.
Vodafone VOD.L is set to miss out on more than €1 billion ($1.15 billion) in potential earnings after Patrick Drahi sold his stake in broadband venture OXG to Societe Generale SOGN.PA.
     
($1 = 0.7481 pounds)
($1 = 0.8728 euros)

(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com))